These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 30384518)

  • 1. Infections associated with bendamustine and anti-CD20 antibody in untreated follicular lymphoma: a real-world study.
    Saburi M; Okuhiro K; Yoshida N; Haruyama T; Moroga Y; Yanai Y; Itani K; Takano K; Honda S; Ono K; Iwanaga M; Sasaki H; Abe M; Kohno K; Nakayama T; Ohtsuka E; Ogata M
    J Clin Exp Hematop; 2023 Sep; 63(3):197-200. PubMed ID: 37518273
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent mild hypokalemia in an otherwise healthy 6-year-old girl: Answers.
    Roumeliotou S; Theohari A; Tsamoulis D; Vafeidou K; Siountri I; Siomou E
    Pediatr Nephrol; 2022 Aug; 37(8):1791-1794. PubMed ID: 35118535
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia.
    Lee-Vergés E; Hanna BS; Yazdanparast H; Rodríguez V; Rodríguez ML; Giró A; Vidal-Crespo A; Rosich L; Amador V; Aymerich M; Villamor N; Delgado J; Lichter P; Pérez-Galán P; López-Guerra M; Campo E; Seiffert M; Colomer D
    Int J Cancer; 2019 Jun; 144(11):2762-2773. PubMed ID: 30468254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia.
    Al-Sawaf O; Bahlo J; Robrecht S; Fischer K; Herling CD; Hoechstetter M; Fink AM; von Tresckow J; Langerbeins P; Cramer P; Stilgenbauer S; Wendtner CM; Eichhorst B; Hallek M; Goede V
    Br J Haematol; 2018 Dec; 183(5):727-735. PubMed ID: 30460980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centre.
    Hock BD; Mulholland KS; Ganly P; McKenzie JL; Pearson JF; MacPherson SA
    Intern Med J; 2019 May; 49(5):598-606. PubMed ID: 30411451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bendamustine-based conditioning prior to autologous stem cell transplantation is associated with high rate of febrile neutropenia and higher mortality.
    Lucijanic M; Prka Z; Jaksic O; Mitrovic Z; Vrkljan A; Pejsa V
    Am J Hematol; 2019 Feb; 94(2):E42-E43. PubMed ID: 30394567
    [No Abstract]   [Full Text] [Related]  

  • 7. Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!
    Dreyling M; Klapper W; Rule S
    Blood; 2018 Dec; 132(26):2722-2729. PubMed ID: 30385481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrolyte Disorders Induced by Antineoplastic Drugs.
    Verzicco I; Regolisti G; Quaini F; Bocchi P; Brusasco I; Ferrari M; Passeri G; Cannone V; Coghi P; Fiaccadori E; Vignali A; Volpi R; Cabassi A
    Front Oncol; 2020; 10():779. PubMed ID: 32509580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery and the development of bendamustine for the treatment of non-Hodgkin lymphoma.
    Munakata W; Tobinai K
    Expert Opin Drug Discov; 2016 Nov; 11(11):1123-1130. PubMed ID: 27598460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bendamustine associated immune suppression and infections during therapy of hematological malignancies.
    Gafter-Gvili A; Polliack A
    Leuk Lymphoma; 2016; 57(3):512-9. PubMed ID: 26696321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired Gitelman Syndrome Secondary to Bendamustine Use.
    Rogers A; Gandhi P; Bautista J; Tang J
    R I Med J (2013); 2018 Nov; 101(9):36-38. PubMed ID: 30384518
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine.
    Alnuaimi K; Lavolé J; Lascoux-Combes C; Roque Afonso AM; Sogni P; Pol S; Mallet V
    Hepatology; 2018 Jun; 67(6):2468-2470. PubMed ID: 29194671
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma.
    Saito H; Maruyama D; Maeshima AM; Makita S; Kitahara H; Miyamoto K; Fukuhara S; Munakata W; Suzuki T; Kobayashi Y; Taniguchi H; Tobinai K
    Blood Cancer J; 2015 Oct; 5(10):e362. PubMed ID: 26495859
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced bendamustine for elderly patients with follicular lymphoma.
    Masamoto Y; Shimura A; Kurokawa M
    Ann Hematol; 2022 Mar; 101(3):713-715. PubMed ID: 34152427
    [No Abstract]   [Full Text] [Related]  

  • 15. Bendamustine therapy associated resolution of anemia and splenomegaly in myelofibrosis.
    Tefferi A; Cerquozzi S; Liaw J
    Am J Hematol; 2016 Feb; 91(2):E6-7. PubMed ID: 26587685
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.